Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity
Market Executive Summary
Global clinical diagnostics market will reach $ 135,531.4 million by 2031, growing by 7.4% annually over 2021-2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.
Highlighted with 82 tables and 94 figures, this 170-page report ?Global Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Region: Trend Forecast and Growth Opportunity? is based on a comprehensive research of the entire global clinical diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
? Market Structure
? Growth Drivers
? Restraints and Challenges
? Emerging Product Trends & Market Opportunities
? Porter?s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Region.
Based on Test, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Lipid Panel
? Infectious Disease Testing
? Liver Panel
? Complete Blood Count (CBC)
? Electrolyte Testing
? Renal Panel
? Other Tests
Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Instruments
? Assay Kits & Reagents
? Software & Services
By Indication the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Cardiovascular
? Cancer
? Infectious Disease
? Stroke
? Chronic Lower Respiratory Diseases
? Diabetes
? Other Indications
By Patient Gender the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Male Patients
? Female Patients
By Age Group the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Age 44 and below
? Age 45-64
? Age 65 and over
By End User the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
? Hospital & Clinics Laboratory
? Diagnostic Laboratory
? Point-of-Care Testing
? Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
? North America (U.S., Canada, and Mexico)
? Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
? APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
? South America (Brazil, Chile, Argentina, Rest of South America)
? MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Test, Product, and Indication, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
? Abbott Laboratories
? Becton, Dickinson and Company
? BioMerieux SA
? Bio-Rad Laboratories Inc.
? Bio-Reference Laboratories
? Bioscientia Healthcare
? Charles River Laboratories
? Danaher Corporation
? Hoffmann-La Roche AG
? Hologic Inc.
? Qiagen NV
? Siemens Healthcare
? Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Table of Contents
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter?s Fiver Forces Analysis 39
3 Segmentation of Global Market by Test 43
3.1 Market Overview by Test 43
3.2 Lipid Panel 45
3.3 Infectious Disease Testing 46
3.4 Liver Panel 47
3.5 Complete Blood Count (CBC) 48
3.6 Electrolyte Testing 49
3.7 Renal Panel 50
3.8 Other Tests 51
4 Segmentation of Global Market by Product 52
4.1 Market Overview by Product 52
4.2 Instruments 54
4.3 Assay Kits & Reagents 55
4.4 Software & Services 56
5 Segmentation of Global Market by Indication 57
5.1 Market Overview by Indication 57
5.2 Cardiovascular 59
5.3 Cancer 60
5.4 Infectious Disease 61
5.5 Stroke 62
5.6 Chronic Lower Respiratory Diseases 63
5.7 Diabetes 64
5.8 Other Indications 65
6 Segmentation of Global Market by Patient Gender 66
6.1 Market Overview by Patient Gender 66
6.2 Male Patients 68
6.3 Female Patients 69
7 Segmentation of Global Market by Age Group 70
7.1 Market Overview by Age Group 70
7.2 Age 44 and below 72
7.3 Age 45-64 73
7.4 Age 65 and over 74
8 Segmentation of Global Market by End User 75
8.1 Market Overview by End User 75
8.2 Hospital & Clinics Laboratory 77
8.3 Diagnostic Laboratory 78
8.4 Point-of-Care Testing 79
8.5 Other End Users 80
9 Segmentation of Global Market by Region 81
9.1 Geographic Market Overview 2021-2031 81
9.2 North America Market 2021-2031 by Country 85
9.2.1 Overview of North America Market 85
9.2.2 U.S. 89
9.2.3 Canada 93
9.2.4 Mexico 95
9.3 European Market 2021-2031 by Country 97
9.3.1 Overview of European Market 97
9.3.2 Germany 101
9.3.3 U.K. 103
9.3.4 France 105
9.3.5 Spain 107
9.3.6 Italy 109
9.3.7 Russia 111
9.3.8 Rest of European Market 113
9.4 Asia-Pacific Market 2021-2031 by Country 115
9.4.1 Overview of Asia-Pacific Market 115
9.4.2 Japan 119
9.4.3 China 122
9.4.4 Australia 124
9.4.5 India 126
9.4.6 South Korea 128
9.4.7 Rest of APAC Region 130
9.5 South America Market 2021-2031 by Country 132
9.5.1 Argentina 135
9.5.2 Brazil 137
9.5.3 Chile 139
9.5.4 Rest of South America Market 141
9.6 MEA Market 2021-2031 by Country 142
9.6.1 UAE 145
9.6.2 Saudi Arabia 147
9.6.3 South Africa 149
9.6.4 Other National Markets 151
10 Competitive Landscape 152
10.1 Overview of Key Vendors 152
10.2 New Product Launch, Partnership, Investment, and M&A 155
10.3 Company Profiles 156
Abbott Laboratories 156
Becton, Dickinson and Company 158
BioMerieux SA 159
Bio-Rad Laboratories Inc. 160
Bio-Reference Laboratories 161
Bioscientia Healthcare 162
Charles River Laboratories 163
Danaher Corporation 164
Hoffmann-La Roche AG 165
Hologic Inc. 166
Qiagen NV 167
Siemens Healthcare 168
Thermo Fisher Scientific 169
RELATED REPORTS 170
List of Figures
List of Figures:
Figure 1. Research Method Flow Chart 13
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 16
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 18
Figure 4. Global Clinical Diagnostics Market, 2021-2031, $ mn 21
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Global Clinical Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2019-2020, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of Global Clinical Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter?s Fiver Forces Analysis of Global Clinical Diagnostics Market 39
Figure 13. Breakdown of Global Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 44
Figure 14. Global Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%) 44
Figure 15. Global Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn 45
Figure 16. Global Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn 46
Figure 17. Global Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn 47
Figure 18. Global Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn 48
Figure 19. Global Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn 49
Figure 20. Global Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn 50
Figure 21. Global Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn 51
Figure 22. Breakdown of Global Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 53
Figure 23. Global Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 53
Figure 24. Global Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn 54
Figure 25. Global Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn 55
Figure 26. Global Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 56
Figure 27. Breakdown of Global Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 58
Figure 28. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 58
Figure 29. Global Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn 59
Figure 30. Global Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn 60
Figure 31. Global Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn 61
Figure 32. Global Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn 62
Figure 33. Global Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn 63
Figure 34. Global Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn 64
Figure 35. Global Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn 65
Figure 36. Breakdown of Global Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 67
Figure 37. Global Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%) 67
Figure 38. Global Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn 68
Figure 39. Global Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn 69
Figure 40. Breakdown of Global Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 71
Figure 41. Global Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%) 71
Figure 42. Global Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn 72
Figure 43. Global Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn 73
Figure 44. Global Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn 74
Figure 45. Breakdown of Global Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 75
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 76
Figure 47. Global Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn 77
Figure 48. Global Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn 78
Figure 49. Global Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn 79
Figure 50. Global Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 80
Figure 51. Global Market Snapshot by Region 81
Figure 52. Geographic Spread of Worldwide Clinical Diagnostics Market, 2021-2031, % of Sales Revenue 82
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 83
Figure 54. North American Clinical Diagnostics Market, 2021-2031, $ mn 86
Figure 55. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 87
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 88
Figure 57. U.S. Clinical Diagnostics Market, 2021-2031, $ mn 90
Figure 58. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, % 90
Figure 59. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, % 91
Figure 60. Canada Clinical Diagnostics Market, 2021-2031, $ mn 93
Figure 61. Clinical Diagnostics Market in Mexico, 2021-2031, $ mn 95
Figure 62. European Clinical Diagnostics Market, 2021-2031, $ mn 98
Figure 63. Breakdown of European Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 99
Figure 64. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 100
Figure 65. Clinical Diagnostics Market in Germany, 2021-2031, $ mn 101
Figure 66. Clinical Diagnostics Market in U.K., 2021-2031, $ mn 103
Figure 67. Clinical Diagnostics Market in France, 2021-2031, $ mn 105
Figure 68. Clinical Diagnostics Market in Spain, 2021-2031, $ mn 107
Figure 69. Clinical Diagnostics Market in Italy, 2021-2031, $ mn 109
Figure 70. Clinical Diagnostics Market in Russia, 2021-2031, $ mn 111
Figure 71. Clinical Diagnostics Market in Rest of Europe, 2021-2031, $ mn 113
Figure 72. Asia-Pacific Clinical Diagnostics Market, 2021-2031, $ mn 116
Figure 73. Breakdown of APAC Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 116
Figure 74. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 118
Figure 75. Clinical Diagnostics Market in Japan, 2021-2031, $ mn 120
Figure 76. Clinical Diagnostics Market in China, 2021-2031, $ mn 122
Figure 77. Clinical Diagnostics Market in Australia, 2021-2031, $ mn 124
Figure 78. Clinical Diagnostics Market in India, 2021-2031, $ mn 126
Figure 79. Clinical Diagnostics Market in South Korea, 2021-2031, $ mn 128
Figure 80. Clinical Diagnostics Market in Rest of APAC, 2021-2031, $ mn 130
Figure 81. South America Clinical Diagnostics Market, 2021-2031, $ mn 133
Figure 82. Breakdown of South America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 133
Figure 83. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 134
Figure 84. Clinical Diagnostics Market in Argentina, 2021-2031, $ mn 135
Figure 85. Clinical Diagnostics Market in Brazil, 2021-2031, $ mn 137
Figure 86. Clinical Diagnostics Market in Chile, 2021-2031, $ mn 139
Figure 87. Clinical Diagnostics Market in Rest of South America, 2021-2031, $ mn 141
Figure 88. Clinical Diagnostics Market in Middle East and Africa (MEA), 2021-2031, $ mn 143
Figure 89. Breakdown of MEA Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 143
Figure 90. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 144
Figure 91. Clinical Diagnostics Market in UAE, 2021-2031, $ mn 145
Figure 92. Clinical Diagnostics Market in Saudi Arabia, 2021-2031, $ mn 147
Figure 93. Clinical Diagnostics Market in South Africa, 2021-2031, $ mn 149
Figure 94. Growth Stage of Global Clinical Diagnostics Industry over the Forecast Period 152
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
